{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:53:41Z","timestamp":1778777621281,"version":"3.51.4"},"reference-count":37,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/Multi\/04378\/2013,SFRH\/BD\/120030\/2016, PD\/BD\/105734\/2014"],"award-info":[{"award-number":["UID\/Multi\/04378\/2013,SFRH\/BD\/120030\/2016, PD\/BD\/105734\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Resistance to chemotherapy is a major problem facing current cancer therapy, which is continuously aiming at the development of new compounds that are capable of tackling tumors that developed resistance toward common chemotherapeutic agents, such as doxorubicin (DOX). Alongside the development of new generations of compounds, nanotechnology-based delivery strategies can significantly improve the in vivo drug stability and target specificity for overcoming drug resistance. In this study, multifunctional gold nanoparticles (AuNP) have been used as a nanoplatform for the targeted delivery of an original anticancer agent, a Zn(II) coordination compound [Zn(DION)2]Cl2 (ZnD), toward better efficacy against DOX-resistant colorectal carcinoma cells (HCT116 DR). Selective delivery of the ZnD nanosystem to cancer cells was achieved by active targeting via cetuximab, NanoZnD, which significantly inhibited cell proliferation and triggered the death of resistant tumor cells, thus improving efficacy. In vivo studies in a colorectal DOX-resistant model corroborated the capability of NanoZnD for the selective targeting of cancer cells, leading to a reduction of tumor growth without systemic toxicity. This approach highlights the potential of gold nanoformulations for the targeting of drug-resistant cancer cells.<\/jats:p>","DOI":"10.3390\/ijms20215510","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T06:47:57Z","timestamp":1572936477000},"page":"5510","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Targeting Cancer Resistance via Multifunctional Gold Nanoparticles"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7190-6438","authenticated-orcid":false,"given":"Pedro","family":"Pedrosa","sequence":"first","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-3937","authenticated-orcid":false,"given":"M. Lu\u00edsa","family":"Corvo","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o do Medicamento (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-2823","authenticated-orcid":false,"given":"Margarida","family":"Ferreira-Silva","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"},{"name":"Instituto de Investiga\u00e7\u00e3o do Medicamento (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Martins","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-4717","authenticated-orcid":false,"given":"Manuela Colla","family":"Carvalheiro","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o do Medicamento (iMed.ULisboa), Faculdade de Farm\u00e1cia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-3522","authenticated-orcid":false,"given":"Pedro M.","family":"Costa","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3182-884X","authenticated-orcid":false,"given":"Carla","family":"Martins","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5403-9352","authenticated-orcid":false,"given":"L. M. D. R. S.","family":"Martins","sequence":"additional","affiliation":[{"name":"Centro de Qu\u00edmica Estrutural (CQE), Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-7095","authenticated-orcid":false,"given":"Pedro V.","family":"Baptista","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2054-4438","authenticated-orcid":false,"given":"Alexandra R.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Applied Molecular Biosciences Unit (UCIBIO), Departamento de Ci\u00eancias da Vida, Faculdade de Ci\u00eancias e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal"},{"name":"Centro de Qu\u00edmica Estrutural (CQE), Instituto Superior T\u00e9cnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/ejic.201300197","article-title":"Cobalt and Zinc Compounds Bearing 1,10-Phenanthroline-5,6-dione or 1,3,5-Triaza-7-phosphaadamantane Derivatives\u2014Synthesis, Characterization, Cytotoxicity, and Cell Selectivity Studies","volume":"2013","author":"Silva","year":"2013","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1039\/C5MB00791G","article-title":"In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(IV) complex","volume":"12","author":"Martins","year":"2016","journal-title":"Mol. BioSyst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1039\/C5DT02744F","article-title":"Synthesis, characterization, thermal properties and antiproliferative potential of copper(II) 4\u2032-phenyl-terpyridine compounds","volume":"45","author":"Ma","year":"2016","journal-title":"Dalt. Trans."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/acs.inorgchem.7b00790","article-title":"Dinuclear Rull (bipy) 2 Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation","volume":"56","author":"Fernandes","year":"2017","journal-title":"Inorg. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.3390\/molecules200916852","article-title":"Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine\u2019s tool Box","volume":"20","author":"Martins","year":"2015","journal-title":"Molecules"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2016.11.021","article-title":"Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents","volume":"245","author":"Fernandes","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/cancers5010296","article-title":"Nanomaterials and autophagy: New insights in cancer treatment","volume":"5","author":"Panzarini","year":"2013","journal-title":"Cancers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.2147\/IJN.S146927","article-title":"Drug delivery to solid tumors: The predictive value of the multicellular tumor spheroid model for nanomedicine screening","volume":"12","author":"Millard","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_9","first-page":"578","article-title":"Cetuximab in advanced non-small cell lung cancer (NSCLC): The showdown?","volume":"6","author":"Sgambato","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/JTO.0b013e3181b624ae","article-title":"Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): A phase I\/II study from the Hoosier Oncology Group","volume":"4","author":"Jalal","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"ref_11","first-page":"603","article-title":"Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression","volume":"7","author":"Ohsaki","year":"2000","journal-title":"Oncol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5306\/wjco.v6.i5.133","article-title":"Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention","volume":"6","author":"Pabla","year":"2015","journal-title":"World J. Clin. Oncol."},{"key":"ref_13","first-page":"222","article-title":"A Phase 2 Study of Cetuximab in Combination with Docetaxel in Chemotherapy-Refractory\/Resistant Patients with Advanced Nonsmall Cell Lung Cancer","volume":"95","author":"Kim","year":"2016","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/annonc\/mdm474","article-title":"Randomized phase II study of cetuximab plus cisplatin\/vinorelbine compared with cisplatin\/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer","volume":"19","author":"Rosell","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/JCO.2009.25.2890","article-title":"Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane\/carboplatin in advanced non-small-cell lung cancer","volume":"28","author":"Harbison","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0194599815617723","article-title":"Analysis of 473 US Head and Neck Cancer Trials (1996\u20132014): Trends, Gaps, and Opportunities","volume":"154","author":"Devaiah","year":"2016","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"ref_17","first-page":"134","article-title":"A comprehensive review of clinical trials on EGFR inhibitors such as cetuximab and panitumumab as monotherapy and in combination for treatment of metastatic colorectal cancer","volume":"7","author":"Yazdi","year":"2015","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/COC.0b013e3181891326","article-title":"High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor","volume":"32","author":"Deng","year":"2009","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/annonc\/mdi006","article-title":"Impact of EGFR expression on colorectal cancer patient prognosis and survival","volume":"16","author":"Spano","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5858\/2008-0586-RAR1.1","article-title":"Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?","volume":"134","author":"Inamura","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_21","first-page":"54","article-title":"Cetuximab in non-small-cell lung cancer","volume":"1","author":"Pirker","year":"2012","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3174\/ajnr.A2054","article-title":"Cetuximab (Erbitux)","volume":"31","author":"Mukherji","year":"2010","journal-title":"Am. J. Neuroradiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2217\/nnm.12.160","article-title":"EGF receptor-targeted nanocarriers for enhanced cancer treatment","volume":"7","author":"Master","year":"2012","journal-title":"Nanomedicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-7992(94)90007-8","article-title":"Adriamycin induces large deletions as a major type of mutation in CHO cells","volume":"325","author":"Yu","year":"1994","journal-title":"Mutat. Res. Lett."},{"key":"ref_26","first-page":"577","article-title":"Mutagenic Responses of Thirteen Anticancer Drugs on Mutation Induction at Multiple Genetic Loci and on Sister Chromatid Exchanges in Chinese Hamster Ovary Cells","volume":"43","author":"Singh","year":"1983","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","article-title":"ROS homeostasis and metabolism: A dangerous liason in cancer cells","volume":"7","author":"Panieri","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jconrel.2016.07.028","article-title":"Accumulating nanoparticles by EPR: A route of no return","volume":"238","author":"Ngoune","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; What is the appropriate target?","volume":"4","author":"Kobayashi","year":"2014","journal-title":"Theranostics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_32","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J. Thorac. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","article-title":"Mechanisms of drug resistance in colon cancer and its therapeutic strategies","volume":"22","author":"Hu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1021\/nn3030223","article-title":"Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing","volume":"6","author":"Conde","year":"2012","journal-title":"ACS Nano"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/17435390.2013.802821","article-title":"Gold-nanobeacons for gene therapy: Evaluation of genotoxicity, cell toxicity and proteome profiling analysis","volume":"8","author":"Conde","year":"2014","journal-title":"Nanotoxicology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1038\/s41598-018-29870-0","article-title":"Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells","volume":"8","author":"Pedrosa","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Costa, P.M. (2018). Chapter 4\u2014Staining Protocols, Academic Press.","DOI":"10.1016\/B978-0-12-812032-3.00004-6"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5510\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:59Z","timestamp":1760189519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["ijms20215510"],"URL":"https:\/\/doi.org\/10.3390\/ijms20215510","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]}}}